The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessAbstract
Non-epithelial ovarian tumours account for approximately 10% of all ovarian cancers. Malignant germ cell tumours (GCTs) occur mainly in young women whereas the most common type of sex cord-stromal tumours (SCSTs), i.e. granulosa cell tumour, occurs more often in middle age and in postmenopausal women [1]. Malignant GCTs represent 5% of all ovarian cancers and 80% of the preadolescent malignant ovarian tumours. SCSTs are rare neoplasms that account for approximately 3%–5% of ovarian malignancies and the majority of ovarian tumours with endocrine manifestations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,312
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
Prat, J. (2014) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2013.10.001 · Cited by 1,364
Self-citationRare cancers are not so rare: The rare cancer burden in Europe
Gatta, G., van der Zwan, J. M., Casali, P. G., Siesling, S., Dei Tos, A. P., Kunkler, I., Otter, R., Licitra, L., Mallone, S., Tavilla, A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.008 · Cited by 809
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Ramos, P., Karnezis, A. N., Craig, D. W., Sekulic, A., Russell, M. L., Hendricks, W. P. D., Corneveaux, J. J., Barrett, M. T., Shumansky, K., Yang, Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.2928 · Cited by 387
Self-citationRecurrent SMARCA4 mutations in small cell carcinoma of the ovary
Jelinic, P., Mueller, J. J., Olvera, N., Dao, F., Scott, S. N., Shah, R., Gao, J., Schultz, N., Gonen, M., Soslow, R. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.2922 · Cited by 379
Schneppenheim, R., Frühwald, M. C., Gesk, S., Hasselblatt, M., Jeibmann, A., Kordes, U., Kreuz, M., Leuschner, I., Subero, J. I. M., Obser, T., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.01.013 · Cited by 348
Loehrer, P. J., Lauer, R., Roth, B. J., Williams, S. D., Kalasinski, L. A., & Einhorn, L. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-7-540 · Cited by 276
Lambertini, M., Ceppi, M., Poggio, F., Peccatori, F. A., Azim, H. A., Ugolini, D., Pronzato, P., Loibl, S., Moore, H. C. F., Partridge, A. H., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv374 · Cited by 228
FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary
Al-Agha, O. M., Huwait, H. F., Chow, C., Yang, W., Senz, J., Kalloger, S. E., Huntsman, D. G., Young, R. H., & Gilks, C. B. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31820a406c · Cited by 220
Karnezis, A. N., Wang, Y., Ramos, P., Hendricks, W. P., Oliva, E., D'Angelo, E., Prat, J., Nucci, M. R., Nielsen, T. O., Chow, C., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4633 · Cited by 217
Self-citationWitkowski, L., Goudie, C., Ramos, P., Boshari, T., Brunet, J., Karnezis, A. N., Longy, M., Knost, J. A., Saloustros, E. S., McCluggage, W. G., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.03.013 · Cited by 135
Self-citationFoulkes, W. D., Clarke, B. A., Hasselblatt, M., Majewski, J., Albrecht, S., & McCluggage, W. G. (2014) · The Journal of Pathology · doi:10.1002/path.4362 · Cited by 125
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Sex Cord Stromal Tumors
Ray-Coquard, I. L., Brown, J., Harter, P., Provencher, D. M., Fong, P. C. C., Maenpaa, J. U., Ledermann, J. A., Emons, G., Rigaud, D. B., Glasspool, R. M., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000249 · Cited by 109
Self-citationSmall cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases
Callegaro‐Filho, D., Gershenson, D. M., Nick, A. M., Munsell, M. F., Ramirez, P. T., Eifel, P. J., Euscher, E. D., Moretti‐Marques, R., Nicolau, S. M., & Schmeler, K. M. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.11.004 · Cited by 95
Karanian, M., Velasco, V., Longy, M., Floquet, A., Arnould, L., Coindre, J., Naoures-Méar, C. L., Avérous, G., Guyon, F., MacGrogan, G. M., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000475 · Cited by 92
Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up
Wilson, M. K., Fong, P. C. C., Mesnage, S. J. L., Chrystal, K. F., Shelling, A. N., Payne, K., MacKay, H. J., Wang, L. E., Laframboise, S., Rouzbahman, M., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.05.011 · Cited by 73
Treatment of Ovarian Cancer in Young Women
Gershenson, D. M. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e318248045b · Cited by 59
Special issues in fertility preservation for gynecologic malignancies
Tomao, F., Peccatori, F. A., Pup, L. D., Franchi, D., Zanagnolo, V. L., Panici, P. B., & Colombo, N. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.024 · Cited by 57
Self-citationChampion, V. L., Williams, S. D., Miller, A. M., Reuille, K. M., Ziner, K. W., Monahan, P. O., Zhao, Q., Gershenson, D. M., & Cella, D. F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.042 · Cited by 48
Chi, E. A., & Schweizer, M. T. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.04.005 · Cited by 37 · cited 1×
“Nevertheless, studies of the management of refractory GCTs are ongoing, with a focus on optimal utilisation of HDCT and ASCT, as well as the role of immune checkpoint inhibitors in refractory GCTs [45].”
Current Management of Refractory Germ Cell Tumors and Future Directions
Allen, J. C., Kirschner, A. N., Scarpato, K. R., & Morgans, A. K. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0572-y · Cited by 27
Therapy Insight: fertility in women after cancer treatment
Morice, P., Pautier, P., Fanchin, R. R. F., Haie-Méder, C., Chauveaud-Lambling, A., Frydman, R., & Frydman, N. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0675 · Cited by 11
Self-citation(2000) · doi:10.1002/1097-0142(20000715)89:2
Cited by
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
Berek, J. S., Renz, M., Kehoe, S., Kumar, L., & Friedlander, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13878 · Cited by 514
Ledermann, J. A., Matias-Guiu, X., Amant, F., Concin, N., Davidson, B., Fotopoulou, C., González-Martin, A., Gourley, C., Leary, A., Lorusso, D., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2023.11.015 · Cited by 333
Self-citationKasikova, L., Hensler, M., Truxova, I., Skapa, P., Laco, J., Belicova, L., Praznovec, I., Vosahlikova, S., Halaska, M. J., Brtnicky, T., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0781-z · Cited by 79
Metadata
- Authors
- Ray-Coquard, I., Morice, P., Lorusso, D., Prat, J., Oaknin, A., Pautier, P., & Colombo, N.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv1-iv18
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4248292785
- Cited by
- 374
- References
- 24
- FWCI
- 23.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.